Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 14, 2022, Fennec Pharmaceuticals Inc. (the "Company") held an annual meeting of shareholders (the "Meeting"). The shareholders approved all proposals considered at the Meeting and approved all nominees of the Company for director, as follows:

1. The following six (6) nominees were elected to serve as directors, each to serve until the next annual meeting of shareholders of the Company or until their respective successor shall have been duly elected or duly approved:





Name of Nominee    Votes For    Votes Withheld   Broker Non-Votes
Dr. Khalid Islam   15,884,541       65,032          5,304,126
Adrian Haigh       15,884,387       65,186          5,304,126
Chris A. Rallis    15,883,822       65,751          5,304,126
Marco Brughera     15,886,736       62,837          5,304,126
Jodi Cook          15,887,034       62,539          5,304,126
Rostislav Raykov   15,884,175       65,398          5,304,126

2. The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote:





Votes For        18,156,862
Votes Withheld    162,413
Abstentions        2,669
Broker Non-Votes     0

3. The resolution to vote on the advisory vote on executive compensation was approved based on the following vote:





Votes For        12,812,365
Votes Against     153,550
Abstentions        52,058
Broker Non-Votes 5,304,126




                                       2

© Edgar Online, source Glimpses